Search research articles
Contact Us
Filters
Showing results (91-100 of 403) with videos related to
Page
of 41
Sort By:
Lancet (London, England)
|
January 21, 1984
Anti-cardiolipin antibodies in neurological diseases
C B Colaco, G Scadding, J Newsom-Davis
JAMA Oncology
|
February 21, 2020
Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer-Reply
David J Pinato, Thomas Newsom-Davis, Mark Bower
Muscle & Nerve
|
August 14, 1998
Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome
P Maddison, J Newsom-Davis, K R Mills
Annals of the New York Academy of Sciences
|
July 21, 1998
Seronegative myasthenia plasmas and non-IgG fractions transiently inhibit nAChR function
C P Plested, J Newsom-Davis, A Vincent
The American Review of Respiratory Disease
|
February 1, 1979
The regional distribution of ventilation and perfusion in paralysis of the diaphragm [proceedings]
L Loh, J M Hughes, J Newsom-Davis
Neurology
|
November 14, 2001
Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
C Buckley, J Newsom-Davis, N Willcox, et al.
Eye (London, England)
|
January 1, 1990
Ocular autonomic nerve function in Lambert-Eaton myasthenic syndrome
C V Clark, J Newsom-Davis, M D Sanders
The Journal of Physiology
|
November 1, 1983
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse
B Lang, J Newsom-Davis, C Prior, et al.
Biochemical Society Transactions
|
May 1, 1996
Cloning and expression of human S-laminin
A Buckel, D Beeson, A Vincent, et al.
Autoimmunity
|
January 1, 1992
Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies
A Roberts, B Lang, A Vincent, et al.
Page
of 41
Search research articles
Search
Showing results (91-100 of 403) with videos related to
Sort By:
Page
of 41
Lancet (London, England)
|
January 21, 1984
Anti-cardiolipin antibodies in neurological diseases
C B Colaco, G Scadding, J Newsom-Davis
JAMA Oncology
|
February 21, 2020
Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer-Reply
David J Pinato, Thomas Newsom-Davis, Mark Bower
Muscle & Nerve
|
August 14, 1998
Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome
P Maddison, J Newsom-Davis, K R Mills
Annals of the New York Academy of Sciences
|
July 21, 1998
Seronegative myasthenia plasmas and non-IgG fractions transiently inhibit nAChR function
C P Plested, J Newsom-Davis, A Vincent
The American Review of Respiratory Disease
|
February 1, 1979
The regional distribution of ventilation and perfusion in paralysis of the diaphragm [proceedings]
L Loh, J M Hughes, J Newsom-Davis
Neurology
|
November 14, 2001
Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
C Buckley, J Newsom-Davis, N Willcox, et al.
Eye (London, England)
|
January 1, 1990
Ocular autonomic nerve function in Lambert-Eaton myasthenic syndrome
C V Clark, J Newsom-Davis, M D Sanders
The Journal of Physiology
|
November 1, 1983
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse
B Lang, J Newsom-Davis, C Prior, et al.
Biochemical Society Transactions
|
May 1, 1996
Cloning and expression of human S-laminin
A Buckel, D Beeson, A Vincent, et al.
Autoimmunity
|
January 1, 1992
Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies
A Roberts, B Lang, A Vincent, et al.
Page
of 41